Hypertension (HTN) or high blood pressure (BP) is a chronic disorder in which the pressure exerted on arteries is elevated. Normal BP at rest is below 120/80 mm of Hg. If there is persistent elevation of BP above 140/90 mmHg, it is considered HTN. The prevalence of HTN in obese individuals is twice as high as in the general population. Leptin is an amino acid protein hormone with a molecular weight of around 16kDa. It is a product of the obese gene (ob) from adipocytes. Previous studies revealed the correlation between serum leptin levels and body mass index. The study's novelty is that we assess the correlation between leptin and insulin levels in hypertensive patients. The current study assesses the correlation between hypertensive patients' serum leptin and serum insulin levels. The study's objectives include assessment of age, gender distribution, blood pressure, and comparison of serum leptin and insulin levels among hypertensive and normotensives. This study was conducted among 50 subjects with hypertension(cases) and 50 subjects without hypertension(controls). The study samples were taken from patients who attended the Department of General Medicine outpatient unit at Sri Siddhartha Medical College, Tumkur, Karnataka, India. Results showed that most of the patients were aged 51 to 60 years, and most of the patients were males. There is no significant difference in the gender or mean age between cases and controls. In conclusion, there is a positive correlation between serum insulin and leptin levels among hypertensive and a negative correlation between serum insulin and leptin levels among normotensives. There is a significant difference in the mean serum leptin and insulin levels between hypertensive and normotensives.

1. Chobain AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL et al., IZZo Jr, et al. eventh report of the joint national committee on prevention, detection, evaluation and treatment of high blood pressure. Hypertension. 2003;42(6):1206-52. doi: 10.1161/01.HYP.0000107251.49515.c2, PMID 14656957.
2. Carretero OA, Oparil S. Definition and etiology of essential hypertension. Circulation. 2005;101(3):329-35.
3. Vedrana V, Radivoje R, Kristina S, Mario C, Tomislav I, Dunja B. Plasma leptin in obesity related hypertension. Period Biol. 2011;113(3):373-6.
4. Zhang Y, Scarpace PJ. The role of Leptin in Leptin resistance and obesity. Physiol Behav. 2006;88(3):249-56. doi: 10.1016/j.physbeh.2006.05.038.
5. Obradovic M, Sudar-Milovanovic E, Soskic S, Essack M, Arya S, Stewart AJ, et al. Leptin and obesity: role and clinical implication. Front Endocrinol (Lausanne). 2021; 12:585887. doi: 10.3389/fendo.2021.585887, PMID 34084149.
6. Wauters M, Considine RV, Van Gaal LF. Human Leptin- from adipocyte hormone to an endocrine mediator. Eur J Endocrinol. 2000;143(3):293-311. doi: 10.1530/eje.0.1430293, PMID 11022169.
7. Goren I, Pfeilschifter J, Frank S. Determination of leptin signaling pathways in human and murine keratinocytes. Biochem Biophys Res Commun. 2003;303(4):1080-5. doi: 10.1016/s0006-291x(03)00480-7, PMID 12684046.
8. Bell BB, Rahmouni K. Leptin as a mediator of obesity-induced hypertension. Curr Obes Rep. 2016 Dec;5(4):397-404. doi: 10.1007/s13679-016-0231-x, PMID 27665107, PMCID PMC5119542.
9. Sitar-T?ut AV, Cozma A, Fodor A, Coste SC, Orasan OH, Negrean V et al. New insights on the relationship between leptin, ghrelin, and leptin/ghrelin ratio enforced by body mass index in obesity and diabetes. Biomedicines. 2021 Nov 10;9(11):1657. doi: 10.3390/biomedicines9111657, PMID 34829886, PMCID PMC8615809.
10. Izquierdo AG, Crujeiras AB, Casanueva FF, Carreira MC. Leptin, Obesity, and Leptin Resistance: Where Are We 25 Years Later? Nutrients. 2019 Nov 8;11(11):2704. doi: 10.3390/nu11112704. PMID: 31717265; PMCID: PMC6893721.
11. Dardeno TA, Chou SH, Moon HS, Chamberland JP, Fiorenza CG, Mantzoros CS. Leptin in human physiology and therapeutics. Front Neuroendocrinol. 2010;31(3):377-93. doi: 10.1016/j.yfrne.2010.06.002, PMID 20600241.
12. Daly PA, Landsberg L. Hypertension in obesity and NIDDM: role of insulin and sympathetic nervous system. Diabetes Care. 1991;14(3):240-8. doi: 10.2337/diacare.14.3.240MedlineGoogle Scholar. PMID 2044439.
13. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, Pedrinelli R, Brandi L, Bevilacqua S. Insulin resistance in essential hypertension. N Engl J Med. 1987 Aug 6;317(6):350-7. doi: 10.1056/NEJM198708063170605. PMID: 3299096.
14. Gebreyes YF, Goshu DY, Geletew TK, Argefa TG, Zemedu TG, Lemu KA, et al. Prevalence of high bloodpressure, hyperglycemia, dyslipidemia, metabolic syndrome and their determinants in Ethiopia: evidences from the National NCDs STEPS Survey, 2015. PLOS ONE. 2018 May 9;13(5):e0194819. doi: 10.1371/journal.pone.0194819, PMID 29742131, PMCID PMC5942803.
15. Armstrong C. JNC 8 guidelines for the management of hypertension in adults. afp [Internet]. 2014;90(7):503-4.
16. Paillaud E, Poisson J, Granier C, Ginguay A, Plonquet A, Conti C et al. Serum leptin levels, nutritional status, and the risk of healthcare-associated infections in hospitalized older adults. Nutrients. 2022 Jan 5;14(1):226. doi: 10.3390/nu14010226, PMID 35011102, PMCID PMC8747117.
17. Srinivasa Nageswara Rao G, Prema G, Priya G, Arumugam SB, Kirthivasan V, Saibabu R et al. Comparison between serum insulin levels and its resistance with biochemical, clinical and anthropometric parameters in south Indian children and adolescents. Indian J Clin Biochem. 2011 Jan;26(1):22-7. doi: 10.1007/s12291-010-0069-z. PMID 22211009, PMCID PMC3068776.
18. Dhungana RR, Pandey AR, Shrestha N. Trends in the prevalence, awareness, treatment, and control of hypertension in Nepal between 2000 and 2025: A systematic review and meta-analysis. Int J Hypertens. 2021;2021:6610649. doi: 10.1155/2021/6610649, PMID 33747559.
19. Lord GM, Matarese G, Howard JK, Baker RJ, Bloom SR, Lechler RI. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature. 1998;394(6696):897-901. doi: 10.1038/29795, PMID 9732873.
20. Martín-Romero C, Santos-Alvarez J, Goberna R, Sánchez-Margalet V. Human Leptin enhances activation and proliferation of human circulating T -lymphocytes. Cell Immunol. 2000;199(1):15-24. doi: 10.1006/cimm.1999.1594, PMID 10675271.
21. Siegmund B, Lehr HA, Fantuzzi G. Leptin: A pivotal mediator of intestinal inflammation in mice. Gastroenterology. 2002;122(7):2011-25. doi: 10.1053/gast.2002.33631, PMID 12055606.
22. Rahmouni K. Leptin-induced sympathetic nerve activation: signaling mechanisms and cardiovascular consequences in obesity. Curr Hypertens Rev. 2010 May 1;6(2):104-209. doi: 10.2174/157340210791170994, PMID 21562617, PMCID PMC3090157.
23. Aizawa-Abe M, Ogawa Y, Masuzaki H, Ebihara K, Satoh N, Iwai H, et al. Pathophysiological role of leptin in obesity-related hypertension. J Clin Invest. 2000;105(9):1243-52. (PMC Free article). doi: 10.1172/JCI8341, PMID 10791999, Google Scholar.
24. Mark AL. Selective leptin resistance revisited. Am J Physiol Regul Integr Comp Physiol. 2013;305(6):R566-81. (PMC Free article). doi: 10.1152/ajpregu.00180.2013, PMID 23883674, Google Scholar.
25. Ma D, Feitosa MF, Wilk JB, Laramie JM, Yu K, Leiendecker-Foster C, et al. Leptin is associated with blood pressure and hypertension in women from the National Heart, Lung, and Blood Institute Family Heart Study. Hypertension. 2009;53(3):473-9. doi: 10.1161/Hypertensionaha.108.118133, PMID 19204185.
26. Xun P, Liu K, Cao W, Sidney S, Williams OD, He K. Fasting insulin level is positively associated with incidence of hypertension among American young adults: a 20-year follow-up study. Diabetes Care. 2012 Jul;35(7):1532-7. doi: 10.2337/dc11-2443. PMID 22511258, PMCID PMC3379592.
27. Singla R, Goyal A, Bedi GK, Rao HK. Study of serum insulin levels in patients of euglycemic essential hypertension: a cross sectional study in north Indian population. Diabetes Metab Syndr. 2013 Oct-Dec;7(4):202-5. doi: 10.1016/j.dsx.2013.10.018. PMID 24290084.
28. Lastra G, Dhuper S, Johnson MS, Sowers JR. Salt, aldosterone, and insulin resistance: impact on the cardiovascular system. Nat Rev Cardiol. 2010;7(10):577-84. doi: 10.1038/nrcardio.2010.123, PMID 20697411.
29. von Schnurbein J, Manzoor J, Brandt S, Denzer F, Kohlsdorf K, Fischer-Posovszky P, et al. Leptin is not essential for obesity-associated hypertension. Obes Facts. 2019;12(4):460-75. doi: 10.1159/000501319. PMID 31357197, PMCID PMC6758712.
30. Bianchi S, Bigazzi R, Valtriani C, Chiapponi I, Sgherri G, Baldari G et al. Elevated serum insulin levels in patients with essential hypertension and microalbuminuria. Hypertension. 1994 Jun;23(6_pt_1 Pt 1):681-7. doi: 10.1161/01.HYP.23.6.681, PMID 8206563.
31. Paz-Filho G, Mastronardi C, Wong ML, Licinio J. Leptin therapy, insulin sensitivity, and glucose homeostasis. Indian J Endocrinol Metab. 2012 Dec;16;Suppl 3:S549-55. doi: 10.4103/2230-8210.105571, PMID 23565489, PMCID PMC3602983.
32. Osegbe I, Okpara H, Azinge E. Relationship between serum leptin and insulin resistance among obese Nigerian women. Ann Afr Med. 2016 Jan-Mar;15(1):14-9. doi: 10.4103/1596-3519.158524, PMID 26857932, PMCID PMC5452686.
33. Kumar R, Mal K, Razaq MK, Magsi M, Memon MK, Memon S, et al. Association of leptin with obesity and insulin resistance. Cureus. 2020;12(12):e12178. doi: 10.7759/cureus.12178, PMID 33489589.